Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.48
-0.31 (-1.16%)
At close: Apr 28, 2026, 4:00 PM EDT
26.51
+0.03 (0.11%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Pfizer Revenue
In the year 2025, Pfizer had annual revenue of $62.58B, down -1.65%. Pfizer had revenue of $17.56B in the quarter ending December 31, 2025, a decrease of -1.16%.
Revenue (ttm)
$62.58B
Revenue Growth
-1.65%
P/S Ratio
2.41
Revenue / Employee
$834,387
Employees
75,000
Market Cap
150.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.58B | -1.05B | -1.65% |
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 96.36B |
| Merck & Co. | 65.01B |
| AbbVie | 61.16B |
| AstraZeneca | 58.74B |
| Novartis AG | 56.67B |
| Sanofi | 54.85B |
| Novo Nordisk | 48.59B |
| Bristol-Myers Squibb Company | 48.19B |
PFE News
- 9 hours ago - Pfizer Stock Is Declining Today: What's Happening? - Benzinga
- 11 hours ago - Pfizer secures deals to keep heart drug free of generic rivals until 2031 - Reuters
- 12 hours ago - Pfizer Reaches Three Settlement Agreements for VYNDAMAX - Business Wire
- 4 days ago - Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy - Reuters
- 5 days ago - Pfizer Transcript: AGM 2026 - Transcripts
- 6 days ago - Pfizer Declares Second-Quarter 2026 Dividend - Business Wire
- 6 days ago - Pfizer GLP-1 weight loss drug available for pre-order in China - Reuters
- 7 days ago - Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 - Business Wire